TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expression

Breast Cancer Research and Treatment

Volumn 42, Issue 2, 1997, Pages 95-101

  Amoils, K D ^a   Bezwoda, W R ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Estrogen receptor; RT PCR; Transforming growth factor beta

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BREAST CANCER; DNA PROBE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA HYBRIDIZATION; SOUTHERN BLOTTING; STATISTICAL ANALYSIS; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031019445     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005785421815     Document Type: Article

References (25)

1. Moses HL, Branum EB, Proper JA, Robinson RA: Transforming growth factor production by chemically transformed cells. Cancer Res 41: 2842-2848, 1981
2. Roberts AB, Anzano MA. Lamb LC, Smith JM, Sporn MB: New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78: 5339-5343, 1981
3. Derynck R, Jarret JA, Chen EY, Eaton DH, Bell JR, Assosian RK, Roberts AB. Sporn MB, Goeddel DV: Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701-705, 1985
4. Knabbe C, Lippman ME, Wakefield LM, Flanders KC. Kasid A. Derynck R, Dickson RB: Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417-428, 1987
5. Barrett-Lee P, Travers M, Luqmani Y, Coombes RC: Transcripts for transforming growth factors in human breast cancer: clinical correlates. Br J Cancer 61: 612-617, 1990
6. Mizukami Y, Nomomura A, Yamada T, Kurumaya H, Hayashi M, Koyasaki N, Taniya T, Nogushi M, Nakamura S, Matsubara F: Immunohistochemical demonstration of growth factors TGF-alpha, TGFbeta, IGF-I and neu oncogene product in benign and malignant breast tissues. Anticancer Res 10: 1115-1126, 1990
7. Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT: Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. J Clin Invest 92: 2569-2576. 1993
8. 1, is implicated in the failure of tamoxifen therapy in human breast cancer. Br J Cancer 63: 609-614, 1991
9. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159. 1987
10. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, 1989, pp 7.43-7.45
11. Derynck R, Rhee L, Chen EY, Van Tilburg A: Intron-exon structure of the human transforming growth factor-β precursor gene. Nucleic Acids Res 15: 3188-3189, 1987
12. Green S, Walter P, Kumar V, Krust A, Bornert J-M, Argos P, Chambon P: Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320: 134-139, 1986
13. Amoils KD, Seymour L, Bezwoda WR: Comparison between immunocytochemical and polymerase chain reaction techniques for detection of oestrogen receptor and transforming growth factor β in breast cancer. Br J Cancer 73 (in press)
14. Roberts AB, Thompson NL, Heine U, Flanders C, Sporn MB: Transforming growth factor-β: possible roles in carcinogenesis. Br J Cancer 57: 594-600. 1988
15. McCune BK, Mullin BR, Flanders KC, Jaffurs WJ, Mullen LT, Sporn MB: Localization of transforming growth factor-β isotypes in lesions of the human breast. Hum Pathol 23: 13-20, 1992
16. Massague J: The transforming growth factor-β family. Ann Rev Cell Biol 6: 597-641, 1990
17. Arrick BA, Korc M. Derynck R: Differential regulation of expression of three transforming growth factor βspecies in human breast cancer cell lines by estradiol. Cancer Res 50: 299-303. 1990
18. 2, are equipotent growth inhibitors of human breast cancer cell lines. J Cell Physiol 141: 353-361, 1989
19. MacCallum J, Bartlett JMS, Thompson AM, Keen JC, Dixon JM, Miller WR: Expression of transforming growth factor beta mRNA isoforms in human breast cancer. Br J Cancer 69: 1006-1009, 1994
20. Welch DR, Fabra A, Nakajima M: Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87: 7678-7682, 1989
21. Walker RA, Dearing SJ: Transforming growth factor β in ductal carcinoma in-situ and invasive carcinoma of the breast. Eur J Cancer 28: 641-644.1990
22. Dublin EA, Barnes DM, Wang DY, King RJB, Levinson DA: TGF alpha and TGF beta expression in mammary carcinoma. J Pathol 170: 15-22, 1993
23. Stewart AJ, Westley BR, May FEB: Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br J Cancer 66: 640-648, 1992
24. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB: Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82: 119-123. 1985
25. Sporn MB, Roberts AB, Wakefield LM, Assosian RK: Transforming growth factor beta: biological function and chemical structure. Science 233: 532-534. 1986